Thomas Kowalski is a Registered US Patent Attorney with over 30 years’ experience. Mr. Kowalski’s practice includes biotech, chemical and medical apparatus litigation, patent prosecution, licensing and counseling. He also represents his clients in procuring and enforcing trademarks.
Mr. Kowalski obtains trademark protection domestically and worldwide, and he enforces trademark rights in the United States. He has also defended clients accused of trademark infringement and negotiated agreements to avoid litigation.
In fulfilling the requirements for American Chemistry Society certification, Mr. Kowalski has extensively studied graduate biochemistry, graduate inorganic chemistry, genetics, computer science and laboratory research, Columbia University and The NASA Goddard Institute for Space Studies (under Carl A. Gottlieb, Ph.D.).
Also while studying at NYU, he was awarded a National Science Foundation Undergraduate Research Participant (NSF-URP) Grant and performed laboratory research at Hunter College, City University of New York (in the laboratory of Joseph J. Dannenberg, Ph.D.). Mr. Kowalski is a member of the editorial board of Pharmaceutical Patent Analyst and Journal of Commercial Biotechnology, and an editorial advisor for Intellectual Property for Nature Biotechnology.
Mr. Kowalski has extensive international experience and has appeared before courts and proceedings throughout the world, including London, England; The Hague, Netherlands; Dusseldorf, Mannheim and Munich, Germany; Vienna, Austria; Tokyo, Japan; and Melbourne and Canberra, Australia. Mr. Kowalski received a B.S. from New York University and a J.D., with honors, from St. John’s University School of Law.
- Represented a biomedical and genomic research center in preparing and prosecuting patent applications and strategic counseling in obtaining allowance and grant and as to third party portfolios and contentious matters.
- Represented Merial, Inc. in a contentious matter: the offense of a patent opposition / nullity brought by Merial Inc. against Intervet International B.V. to clear away an invalid patent.
- Represented a leader in T-cell therapy in patent prosecution, licensing counseling, and strategy including as to clearing away third party invalid patent through ex parte means that avoided contentious matters.
- New York
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Western District of New York
- Supreme Court of the United States
- American Bar Association
- New York State Bar Association
- New York Intellectual Property Law Association (NYIPLA)
- Intellectual Property for Nature Biotechnology
- Practising Law Institute Faculty
Rate : $$$$